MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Dendreon (NASDAQ: DNDN), #10 (Biotech-Patent Board-2007),
Finance & Acquisitions: Dendreon
Parents
2013: The $100M Club: Where the Major League Life Sciences Companies Are (2013)
Dendreon (NASDAQ: DNDN), #10 (Biotech-Patent Board-2007),
Children
2011: An Open Letter to Dendreon’s Chairman (2011)
2011: Dendreon Adds Another $80M (2011)
2011: Dendreon Seeks $500M Debt Deal (2011)
2013: Drug Maker Dendreon Corporation Seeking a Buyer (2013)
2015: Biotech’s Coming Cancer Cure_CAR-T
Initial investors in Juno include technology venture capital firm Arch Venture Partners of Seattle and the Alaska Permanent Fund
Jumps
*Key People: Dendreon
Organization & Developments: Dendreon